fda warning letters compounded semaglutide november 2025 "semaglutide" is not FDA-approved Drug compounders sue FDA over

Neuron 108 , 11461162.e1110 (2020)

Tirzepatide, the active ingredient in Mounjaro, works by activating GLP-1 and GIP receptors in the brain to reduce hunger signals and slow stomach emptying

Gastrointestinal side effects such as nausea, vomiting, and diarrhoea are common and may reduce quality of life

When these foundational elements are in place, targeted supplementation with NAC or comprehensive botanical formulations can provide meaningful additional support for long-term liver wellness

It may help boost fat metabolism, making it a popular supplement for those looking to lose weight or improve exercise performance